KNSA — Kiniksa Pharmaceuticals International, plc stock price, charts and financials

QT75Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is a Healthcare company in the Medical - Pharmaceuticals industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
75.99
+2.58+3.51%
OverviewShort InterestFilings
KNSAQT75Kiniksa Pharmaceuticals International, plc·NASDAQ
75.99+3.51%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 28, 202610-QQuarterly report
Jul 28, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 26, 20268-KCurrent report
May 26, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20264Statement of changes in beneficial ownership
May 01, 20268-KCurrent report
May 01, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 29, 20264Statement of changes in beneficial ownership
Apr 28, 20268-KCurrent report
#1 / 25 of 426
Page
▼
/ 18